Medical Science Liaison – NMOSD & gMG (Rare Disease)

Amgen; Baltimore (MD); On-site; USD 157,000 - 212,000; Full time

Benefits offered by this job

Remote and hybrid work options

Competitive benefits and retirement &

Job summary

Amgen Inc. is seeking a Medical Science Liaison for NMOSD and gMG-Rare Disease to cover the MD, DE, DC, and Northern VA territory. The role emphasizes scientific engagement with healthcare partners, presenting data, and supporting local R&D tactics.

You will collaborate with cross-functional teams to advance Amgen’s scientific platform, educate about clinical value, and contribute to investigator-initiated research while maintaining compliance and clinical acumen.

Qualifications

• Doctorate or Master’s with Medical Affairs experience, or Bachelor’s with Medical Affairs experience.
• PharmD, PhD, MD, or DO (other doctoral degrees considered).
• Two years of proven experience in scientific or medical affairs at a biotech or pharmaceutical company.
• Three or more years of clinical practice, clinical research, or medical research.

Responsibilities

• Support the MSL TA head and local TA lead in developing local territory R&D tactics.
• Communicate accurate, clear, and valued information regarding Amgen science and products to the medical community.
• Provide field observations and insights to internal collaborators.
• Lead and participate on project teams that support MSL strategies and tactics.
• Develop and implement local scientific engagement plans and OL plans.
• Support speaker training and ensure data updates for speakers.

Education

Doctorate degree

Master’s degree

Bachelor’s degree

Job description

Amgen Inc. is seeking a Medical Science Liaison for NMOSD and gMG-Rare Disease to cover the MD, DE, DC, and Northern VA territory. The role emphasizes scientific engagement with healthcare partners, presenting data, and supporting local R&D tactics.

You will collaborate with cross-functional teams to advance Amgen’s scientific platform, educate about clinical value, and contribute to investigator-initiated research while maintaining compliance and clinical acumen.